Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for fintepla
Fintepla (finerenone) is a prescription medication used to treat chronic kidney disease (CKD) in adults with type 2 diabetes. Because it’s a newer drug, its list price (also called the “average wholesale price” or “MSRP”) can vary depending on a number of factors:
NOTE: These figures are estimates; the actual cost can differ substantially for a particular pharmacy or insurer.
Pharmacies generally mark up the drug to cover dispensing costs and overhead, but the net revenue they receive after all rebates is often lower than the WAC.
The cost of Fintepla for a pharmacy depends on negotiated rebates, the country, and whether the pharmacy is a specialty or retail site. The list price in the U.S. is roughly $1,200–$1,400/month, but the pharmacy’s net cost after discounts is usually lower. For the most accurate figure, contact the manufacturer’s pharmacy liaison or your pharmacy benefit manager.
Other Questions About Fintepla :